https://www.almirall.it 2026-07-24T08:37:55+00:00 weekly 1 https://www.almirall.it/azienda 2026-09-01T15:32:26+00:00 weekly 1 https://www.almirall.it/azienda/chi-siamo 2026-09-09T13:46:39+00:00 weekly 1 https://www.almirall.it/azienda/fornitori 2026-09-02T09:16:41+00:00 weekly 1 https://www.almirall.it/azienda/scopo 2026-07-10T10:20:06+00:00 weekly 1 https://www.almirall.it/pazienti 2026-07-16T12:14:44+00:00 weekly 1 https://www.almirall.it/azienda/sedi 2026-07-02T09:02:07+00:00 weekly 1 https://www.almirall.it/azienda/sostenibilita/persone 2026-07-13T12:22:02+00:00 weekly 1 https://www.almirall.it/azienda/sostenibilita/principi 2026-07-23T08:48:10+00:00 weekly 1 https://www.almirall.it/pazienti/benessere-psicologico 2026-06-03T16:09:23+00:00 weekly 1 https://www.almirall.it/pazienti/impegno/campagne 2026-08-26T11:29:20+00:00 weekly 1 https://www.almirall.it/azienda/sostenibilita/pianeta 2026-07-10T10:10:01+00:00 weekly 1 https://www.almirall.it/azienda/sostenibilita 2026-09-04T12:47:36+00:00 weekly 1 https://www.almirall.it/azienda/sostenibilita/pazienti 2026-05-12T14:58:54+00:00 weekly 1 https://www.almirall.it/azienda/sostenibilita/partner 2026-06-24T18:43:26+00:00 weekly 1 https://www.almirall.it/pazienti/storie 2026-07-28T12:40:26+00:00 weekly 1 https://www.almirall.it/pazienti/impegno/campagne/sanctuary-salon 2026-09-09T13:30:07+00:00 weekly 1 https://www.almirall.it/investitori 2026-05-18T10:57:04+00:00 weekly 1 https://www.almirall.it/investitori/comunicazioni-CNMV 2026-05-12T15:50:29+00:00 weekly 1 https://www.almirall.it/investitori/governance-aziendale 2026-05-12T17:50:44+00:00 weekly 1 https://www.almirall.it/investitori/governance-aziendale/assemblea-annuale 2026-05-12T15:51:45+00:00 weekly 1 https://www.almirall.it/innovazione/studi-clinici 2026-07-13T12:38:32+00:00 weekly 1 https://www.almirall.it/innovazione/collaborazione-rs 2026-07-13T12:40:41+00:00 weekly 1 https://www.almirall.it/innovazione/partner 2026-05-12T09:26:56+00:00 weekly 1 https://www.almirall.it/investitori/governance-aziendale/accordi 2026-05-12T15:50:08+00:00 weekly 1 https://www.almirall.it/investitori/governance-aziendale/consiglio-amministrazione 2026-05-12T15:29:49+00:00 weekly 1 https://www.almirall.it/investitori/governance-aziendale/commissioni-consiglio 2026-05-12T15:29:42+00:00 weekly 1 https://www.almirall.it/dermatologia 2026-07-08T10:34:00+00:00 weekly 1 https://www.almirall.it/investitori/report/annuale 2026-05-12T15:29:14+00:00 weekly 1 https://www.almirall.it/investitori/report/annuale/2021 2026-05-12T15:29:06+00:00 weekly 1 https://www.almirall.it/innovazione 2026-06-24T14:15:48+00:00 weekly 1 https://www.almirall.it/innovazione/letteratura-scientifica 2026-05-27T05:58:46+00:00 weekly 1 https://www.almirall.it/investitori/informazioni-borsistiche 2026-05-12T15:48:27+00:00 weekly 1 https://www.almirall.it/investitori/informazioni-borsistiche/performance-azioni 2026-05-12T15:48:11+00:00 weekly 1 https://www.almirall.it/investitori/informazioni-borsistiche/capitale-sociale 2026-05-12T15:49:45+00:00 weekly 1 https://www.almirall.it/investitori/informazioni-borsistiche/copertura-analisti 2026-05-12T15:49:53+00:00 weekly 1 https://www.almirall.it/investitori/informazioni-borsistiche/azioni-finanziamento 2026-05-12T15:48:18+00:00 weekly 1 https://www.almirall.it/investitori/dati-finanziari/risultati-conti 2026-05-12T15:48:48+00:00 weekly 1 https://www.almirall.it/investitori/dati-finanziari/informazioni-pubbliche 2026-05-12T15:48:41+00:00 weekly 1 https://www.almirall.it/investitori/dati-finanziari/materiali-informativi 2026-05-12T15:30:13+00:00 weekly 1 https://www.almirall.it/innovazione/pipeline 2026-05-12T15:19:59+00:00 weekly 1 https://www.almirall.it/investitori/leadership 2026-05-12T15:29:32+00:00 weekly 1 https://www.almirall.it/investitori/report 2026-05-12T15:50:00+00:00 weekly 1 https://www.almirall.it/actualites-media/sala-stampa 2026-06-03T14:00:55+00:00 weekly 1 https://www.almirall.it/pazienti/impegno 2026-09-07T11:40:52+00:00 weekly 1 https://www.almirall.it/investitori/governance-aziendale/compliance 2026-05-12T15:30:07+00:00 weekly 1 https://www.almirall.it/azienda/integrita 2026-06-24T18:06:27+00:00 weekly 1 https://www.almirall.it/politica-privacy 2026-05-13T13:00:34+00:00 weekly 1 https://www.almirall.it/termini-condizioni 2026-07-16T12:08:06+00:00 weekly 1 https://www.almirall.it/politica-privacy-hcp 2026-05-13T12:58:09+00:00 weekly 1 https://www.almirall.it/politica-accessibilita 2026-06-30T07:30:16+00:00 weekly 1 https://www.almirall.it/azienda/faq 2026-07-08T11:14:01+00:00 weekly 1 https://www.almirall.it/azienda/faq/prodotti 2026-06-03T15:46:55+00:00 weekly 1 https://www.almirall.it/azienda/faq/patologia 2026-06-03T15:46:08+00:00 weekly 1 https://www.almirall.it/azienda/faq/aree-terapeutiche 2026-06-03T15:45:16+00:00 weekly 1 https://www.almirall.it/investitori/leadership/comitato-direzione 2026-05-12T15:29:23+00:00 weekly 1 https://www.almirall.it/azienda/storia 2026-06-10T07:52:37+00:00 weekly 1 https://www.almirall.it/investitori/governance-aziendale/direttore-governance 2026-05-12T15:29:59+00:00 weekly 1 https://www.almirall.it/contatti/segnala-effetto-avverso 2026-09-02T09:48:58+00:00 weekly 1 https://www.almirall.it/contatti 2026-09-02T09:49:00+00:00 weekly 1 https://www.almirall.it/cookie-policy 2026-05-13T13:04:10+00:00 weekly 1 https://www.almirall.it/politiche-consiglio 2026-09-02T09:25:53+00:00 weekly 1 https://www.almirall.it/actualites-media/contatto 2026-05-12T16:29:26+00:00 weekly 1 https://www.almirall.it/actualites-media/calendario-eventi 2026-05-12T15:51:28+00:00 weekly 1 https://www.almirall.it/actualites-media 2026-07-22T09:43:58+00:00 weekly 1 https://www.almirall.it/avvisi 2026-05-11T10:33:18+00:00 weekly 1 https://www.almirall.it/contatti/media 2026-05-13T12:33:15+00:00 weekly 1 https://www.almirall.it/contatti/investitori 2026-05-13T12:31:49+00:00 weekly 1 https://www.almirall.it/contatti/ricerca-sviluppo 2026-05-12T16:42:03+00:00 weekly 1 https://www.almirall.it/contatti/persone-cultura 2026-05-19T10:05:15+00:00 weekly 1 https://www.almirall.it/contatti/partner 2026-05-12T16:40:30+00:00 weekly 1 https://www.almirall.it/contatti/informazioni-mediche 2026-05-12T16:41:02+00:00 weekly 1 https://www.almirall.it/contatti/aiutaci-migliorare 2026-06-25T06:39:44+00:00 weekly 1 https://www.almirall.it/actualites-media/risorse-media 2026-06-03T14:10:55+00:00 weekly 1 https://www.almirall.it/pazienti/impegno/campagne/sanctuary-salon/pazienti 2026-06-24T14:34:05+00:00 weekly 1 https://www.almirall.it/informativa-privacy-carriere 2026-05-19T10:11:12+00:00 weekly 1 https://www.almirall.it/sicurezza-farmaci 2026-05-12T10:18:19+00:00 weekly 1 https://www.almirall.it/termini-utilizzo 2026-06-25T06:36:39+00:00 weekly 1 https://www.almirall.it/azienda/sostenibilita/trasparenza 2026-09-08T15:44:26+00:00 weekly 1 https://www.almirall.it/informativa-privacy-globale-eventi 2026-07-13T07:53:56+00:00 weekly 1 https://www.almirall.it/professionisti-sanitari/prodotti 2026-09-09T12:47:13+00:00 weekly 1 https://www.almirall.it/professionisti-sanitari 2026-09-09T12:52:45+00:00 weekly 1 https://www.almirall.it/news/almirall-recognized-distinguished-corporate-leader-american-skin-association-unveiled-patient 2026-04-01T09:41:04+00:00 weekly 1 https://www.almirall.it/news/fda-approves-duaklirr-new-drug-application-chronic-obstructive-pulmonary-disease-copd 2026-04-01T09:41:04+00:00 weekly 1 https://www.almirall.it/news/almirall-and-hitgen-will-develop-novel-oral-compounds-atopic-dermatitis 2026-04-01T09:41:04+00:00 weekly 1 https://www.almirall.it/news/nice-provisionally-approves-almiralls-ilumetrirv-tildrakizumab-cost-effective-option-adults 2026-04-01T09:41:06+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-late-breaking-oral-presentation-kx2-391-ointment-two-phase-iii-studies 2026-04-01T09:41:06+00:00 weekly 1 https://www.almirall.it/news/almirall-nuevolution-partnership-achieves-first-collaboration-milestone-dermatology-diseases 2026-04-01T09:41:07+00:00 weekly 1 https://www.almirall.it/news/almiralls-full-year-2018-results 2026-04-01T09:41:07+00:00 weekly 1 https://www.almirall.it/news/almirall-and-dermira-enter-option-and-license-agreement-european-rights-lebrikizumab 2026-04-01T09:41:08+00:00 weekly 1 https://www.almirall.it/news/almirallshare-successful-platform-find-innovative-solutions-medical-dermatology 2026-04-01T09:41:08+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-late-breaking-oral-presentation-kx2-391-ointment-two-phase-iii-studies-0 2026-04-01T09:41:08+00:00 weekly 1 https://www.almirall.it/news/novel-oral-antibiotic-treatment-seysaratm-sarecycline-now-available-us 2026-04-01T09:41:10+00:00 weekly 1 https://www.almirall.it/news/francesca-domenech-wuttke-new-chief-digital-officer-and-new-member-management-board-almirall 2026-04-01T09:41:10+00:00 weekly 1 https://www.almirall.it/news/almirall-sa-present-jp-morgan-healthcare-conference-san-francisco 2026-04-01T09:41:10+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-successful-pricing-eu250-mm-offering-senior-unsecured-conditionally 2026-04-01T09:41:11+00:00 weekly 1 https://www.almirall.it/news/almirall-refinance-us-medical-dermatology-acquisition 2026-04-01T09:41:11+00:00 weekly 1 https://www.almirall.it/news/almirall-launches-ilumetrir-germany-moderate-severe-chronic-plaque-psoriasis-adults 2026-04-01T09:41:13+00:00 weekly 1 https://www.almirall.it/news/almirall-9m-2018-business-results-strong-business-momentum 2026-04-01T09:41:13+00:00 weekly 1 https://www.almirall.it/news/fda-approves-seysaratm-new-chemical-entity-moderate-severe-acne 2026-04-01T09:41:14+00:00 weekly 1 https://www.almirall.it/news/almirall-closes-agreement-allergan-and-acquires-its-us-medical-dermatology-portfolio 2026-04-01T09:41:14+00:00 weekly 1 https://www.almirall.it/news/european-commission-approves-almiralls-ilumetrir-tildrakizumab-moderate-severe-chronic-plaque 2026-04-01T09:41:15+00:00 weekly 1 https://www.almirall.it/news/transformational-transaction-almirall-acquire-us-medical-dermatology-portfolio-allergan 2026-04-01T09:41:15+00:00 weekly 1 https://www.almirall.it/news/strong-h1-2018-business-results-upgrading-ebitda-guidance 2026-04-01T09:41:17+00:00 weekly 1 https://www.almirall.it/news/almirall-receives-positive-chmp-opinion-new-anti-il23-tildrakizumab-treatment-patients 2026-04-01T09:41:17+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-both-phase-iii-trials-kx2-391-actinic-keratosis-achieved-primary-endpoint 2026-04-01T09:41:18+00:00 weekly 1 https://www.almirall.it/news/almirall-seeks-new-compounds-improve-skin-health 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/thermi-announces-settlement-patent-infringement-litigation-viveve 2026-04-01T09:41:18+00:00 weekly 1 https://www.almirall.it/news/almirall-q1-2018-encouraging-financial-results 2026-04-01T09:41:20+00:00 weekly 1 https://www.almirall.it/news/almiralls-full-year-2017-results 2026-04-01T09:41:20+00:00 weekly 1 https://www.almirall.it/news/thermi-and-sinclair-terminate-their-collaboration-silhouette-instalifttm 2026-04-01T09:41:21+00:00 weekly 1 https://www.almirall.it/news/almirall-and-athenex-announce-strategic-partnership-treatment-actinic-keratosis 2026-04-01T09:41:21+00:00 weekly 1 https://www.almirall.it/news/phase-iv-ascent-trial-shows-tudorza-reduces-copd-exacerbations-and-demonstrates-cardiovascular 2026-04-01T09:41:22+00:00 weekly 1 https://www.almirall.it/news/almiralls-q3-results-2017 2026-04-01T09:41:22+00:00 weekly 1 https://www.almirall.it/news/new-randomized-controlled-study-confirms-efficacy-and-tolerability-profile-sativexr-treatment 2026-04-01T09:41:24+00:00 weekly 1 https://www.almirall.it/news/almirall-launches-skilarencer-europe-moderate-severe-chronic-plaque-psoriasis 2026-04-01T09:41:24+00:00 weekly 1 https://www.almirall.it/news/almirall-renews-its-corporate-identity-aligned-its-focus-skin-health 2026-04-01T09:41:25+00:00 weekly 1 https://www.almirall.it/news/phase-iii-amplify-study-shows-duaklir-significantly-improves-lung-function-moderate-very 2026-04-01T09:41:25+00:00 weekly 1 https://www.almirall.it/news/almirall-appoints-peter-guenter-new-ceo 2026-04-01T09:41:25+00:00 weekly 1 https://www.almirall.it/news/almiralls-h1-results-2017-reiterating-recent-guidance 2026-04-01T09:41:27+00:00 weekly 1 https://www.almirall.it/news/almirall-collaborates-icmab-csic-and-leitat-technology-center-nanomedicine-applied-dermatology 2026-04-01T09:41:27+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-guidance-update-2017 2026-04-01T09:41:28+00:00 weekly 1 https://www.almirall.it/news/international-experts-elaborate-consensus-effects-present-and-potential-medical-utilities 2026-04-01T09:41:28+00:00 weekly 1 https://www.almirall.it/news/almiralls-q1-results-2017-driven-dermatology-europe 2026-04-01T09:41:28+00:00 weekly 1 https://www.almirall.it/news/data-tildrakizumab-clinical-development-program-presented-2017-american-academy-dermatology 2026-04-01T09:41:30+00:00 weekly 1 https://www.almirall.it/news/almirall-full-year-2016-results-strong-dermatology-results-and-promising-pipeline 2026-04-01T09:41:30+00:00 weekly 1 https://www.almirall.it/news/almirall-y-mercachem-anuncian-una-colaboracion-para-el-desarrollo-de-bloqueadores-de 2026-04-01T09:41:30+00:00 weekly 1 https://www.almirall.it/news/almirall-and-nuevolution-enter-strategic-collaboration-develop-rorgt-inhibitors-treatment 2026-04-01T09:41:31+00:00 weekly 1 https://www.almirall.it/news/almirall-9m-results-2016-strong-derma-performance-eu-and-solid-progress-us 2026-04-01T09:41:31+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-restructuring-plan-spain 2026-04-01T09:41:32+00:00 weekly 1 https://www.almirall.it/news/almirall-h1-results-2016-growth-total-revenues-and-net-sales-driven-dermatology 2026-04-01T09:41:32+00:00 weekly 1 https://www.almirall.it/news/almirall-and-bicosome-enter-collaboration-and-sublicense-agreement-development-topical-drug 2026-04-01T09:41:32+00:00 weekly 1 https://www.almirall.it/news/almiralls-q1-results-2016-track-achieve-yearly-guidance 2026-04-01T09:41:34+00:00 weekly 1 https://www.almirall.it/news/almirall-reduces-its-accident-rate-69-spain-2015 2026-04-01T09:41:34+00:00 weekly 1 https://www.almirall.it/news/almirall-full-year-2015-results-normalized-net-income-growth-90 2026-04-01T09:41:34+00:00 weekly 1 https://www.almirall.it/news/almirall-closes-acquisition-thermigen-llc-entering-aesthetics-market 2026-04-01T09:41:36+00:00 weekly 1 https://www.almirall.it/news/almirall-exercises-call-option-acquire-100-thermigen-llc 2026-04-01T09:41:36+00:00 weekly 1 https://www.almirall.it/news/almirall-reaches-agreement-acquire-100-poli-group 2026-04-01T09:41:37+00:00 weekly 1 https://www.almirall.it/news/almirall-has-acquired-rights-veltinr-and-altabaxr-stiefel-gsk-company-exchange-its 2026-04-01T09:41:37+00:00 weekly 1 https://www.almirall.it/news/almiralls-september-ytd-results-2015-operational-business-outperformance-driven-dermatology 2026-04-01T09:41:38+00:00 weekly 1 https://www.almirall.it/news/almirall-closes-15-million-strategic-investment-suneva-medical 2026-04-01T09:41:38+00:00 weekly 1 https://www.almirall.it/news/almiralls-h1-results-2015-growth-driven-strong-sales-increase-dermatology 2026-04-01T09:41:39+00:00 weekly 1 https://www.almirall.it/news/almiralls-q1-results-2015-growth-acceleration-driven-dermatology 2026-04-01T09:41:39+00:00 weekly 1 https://www.almirall.it/news/almirall-full-year-2014-results-line-guidance 2026-04-01T09:41:39+00:00 weekly 1 https://www.almirall.it/news/almirall-finaliza-el-acuerdo-con-astrazeneca-en-el-area-respiratoria 2026-04-01T09:41:41+00:00 weekly 1 https://www.almirall.it/news/almiralls-aclidinium-bromideformoterol-fumarate-recommended-approval-europe-treat-copd 2026-04-01T09:41:41+00:00 weekly 1 https://www.almirall.it/news/almirall-agrees-strategic-transaction-astrazeneca-respiratory-disease 2026-04-01T09:41:42+00:00 weekly 1 https://www.almirall.it/news/almiralls-h1-results-2014-continued-growth-acceleration 2026-04-01T09:41:42+00:00 weekly 1 https://www.almirall.it/news/almiralls-q1-results-2014-growth-acceleration 2026-04-01T09:41:42+00:00 weekly 1 https://www.almirall.it/news/forest-laboratories-and-almirall-provide-update-fixed-dose-combination-aclidinium-and 2026-04-01T09:41:44+00:00 weekly 1 https://www.almirall.it/news/index-pharmaceuticals-and-almirall-enter-license-agreement-european-rights-phase-iii-drug 2026-04-01T09:41:44+00:00 weekly 1 https://www.almirall.it/news/almirall-completed-senior-notes-pricing-325-million-euros-7-year-maturity-and-4625-annual 2026-04-01T09:41:46+00:00 weekly 1 https://www.almirall.it/news/almiralls-accident-rate-spain-2013-down-20 2026-04-01T09:41:46+00:00 weekly 1 https://www.almirall.it/news/almiralls-full-year-results-2013-setting-foundations-accelerating-growth 2026-04-01T09:41:46+00:00 weekly 1 https://www.almirall.it/news/almirall-reaches-agreement-implement-reestructuring-plan-spain 2026-04-01T09:41:47+00:00 weekly 1 https://www.almirall.it/news/almirall-reaches-agreement-acquire-aqua-pharmaceuticals-us-based-specialty-dermatology-company 2026-04-01T09:41:47+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-reorganization-program-affecting-group-europe 2026-04-01T09:41:47+00:00 weekly 1 https://www.almirall.it/news/around-clock-symptom-relief-vital-many-millions-chronic-obstructive-pulmonary-disease-copd 2026-04-01T09:41:49+00:00 weekly 1 https://www.almirall.it/news/almiralls-q3-track-deliver-year-guidance-eklirar-genuairr-s-global-rollout-continues 2026-04-01T09:41:49+00:00 weekly 1 https://www.almirall.it/news/aclidinium-and-formoterol-fixed-dose-combination-copd-submitted-registration-europe 2026-04-01T09:41:50+00:00 weekly 1 https://www.almirall.it/news/aclidinium-chosen-one-best-spanish-therapeutic-innovations-international-reach 2026-04-01T09:41:50+00:00 weekly 1 https://www.almirall.it/news/new-data-reinforce-efficacy-and-safety-profile-sativexr-multiple-sclerosis-spasticity 2026-04-01T09:41:50+00:00 weekly 1 https://www.almirall.it/news/importance-24-hours-symptom-relief-those-suffering-copd 2026-04-01T09:41:51+00:00 weekly 1 https://www.almirall.it/news/international-pharmaceutical-company-almirall-expands-global-footprint-new-canadian-affiliate 2026-04-01T09:41:51+00:00 weekly 1 https://www.almirall.it/news/almiralls-h1-executing-growth-platforms-financial-delivery-track 2026-04-01T09:41:53+00:00 weekly 1 https://www.almirall.it/news/almirall-50-below-pharmaceutical-sector-accident-rate 2026-04-01T09:41:53+00:00 weekly 1 https://www.almirall.it/news/almirall-maintains-its-commitment-environment-spain-and-germany 2026-04-01T09:41:54+00:00 weekly 1 https://www.almirall.it/news/almirall-pioneer-spain-being-awarded-iso-500012011-energy-management-system-certification 2026-04-01T09:41:54+00:00 weekly 1 https://www.almirall.it/news/constellar-linaclotide-first-approved-prescription-therapy-new-class-treatments-adults-ibs-c 2026-04-01T09:41:54+00:00 weekly 1 https://www.almirall.it/news/survey-reveals-two-five-european-persons-multiple-sclerosis-ms-under-35-are-unable-work-or 2026-04-01T09:41:56+00:00 weekly 1 https://www.almirall.it/news/almirall-begins-transformation 2026-04-01T09:41:56+00:00 weekly 1 https://www.almirall.it/news/almirall-and-forest-laboratories-announce-positive-results-second-phase-iii-study-aclidinium 2026-04-01T09:41:57+00:00 weekly 1 https://www.almirall.it/news/almirall-and-forest-laboratories-announce-positive-results-phase-iii-study-aclidinium-and 2026-04-01T09:41:57+00:00 weekly 1 https://www.almirall.it/news/almirall-presents-latest-news-respiratory-diseases 2026-04-01T09:41:58+00:00 weekly 1 https://www.almirall.it/news/2012-results-line-guidance-positioning-almirall-transformative-growth-2013 2026-04-01T09:41:58+00:00 weekly 1 https://www.almirall.it/news/coordination-among-professionals-crucial-good-vascular-patient-care 2026-04-01T09:42:00+00:00 weekly 1 https://www.almirall.it/news/almirall-commercialises-neurofarmagen-innovative-genetic-test 2026-04-01T09:42:00+00:00 weekly 1 https://www.almirall.it/news/eklirar-genuairr-almirall-available-spain-treatment-copd 2026-04-01T09:42:00+00:00 weekly 1 https://www.almirall.it/news/almirall-celebrates-10-years-italy 2026-04-01T09:42:01+00:00 weekly 1 https://www.almirall.it/news/almiralls-financial-calendar-2013 2026-04-01T09:42:01+00:00 weekly 1 https://www.almirall.it/news/almirall-and-forest-laboratories-announce-commercial-availability-tudorzatm-pressairtm-us 2026-04-01T09:42:01+00:00 weekly 1 https://www.almirall.it/news/constellar-linaclotide-approved-europe-treatment-irritable-bowel-syndrome-constipation-ibs-c 2026-04-01T09:42:05+00:00 weekly 1 https://www.almirall.it/news/almirall-appoints-karin-louise-dorrepaal-new-independent-board-member 2026-04-01T09:42:05+00:00 weekly 1 https://www.almirall.it/news/3rd-quarter-results 2026-04-01T09:42:05+00:00 weekly 1 https://www.almirall.it/news/low-awareness-chronic-obstructive-pulmonary-disease-copd-confirmed-recent-survey 2026-04-01T09:42:07+00:00 weekly 1 https://www.almirall.it/news/almirall-invests-personalised-medicine-becoming-part-share-capital-ab-biotics 2026-04-01T09:42:07+00:00 weekly 1 https://www.almirall.it/news/almirall-incorporates-gerhard-mayr-board-directors 2026-04-01T09:42:08+00:00 weekly 1 https://www.almirall.it/news/sativexr-confirms-clinically-relevant-benefits-multiple-sclerosis-spasticity 2026-04-01T09:42:08+00:00 weekly 1 https://www.almirall.it/news/almirall-licenses-aclidinium-invida-australia-and 2026-04-01T09:42:09+00:00 weekly 1 https://www.almirall.it/news/linaclotide-receives-positive-chmp-opinion-treatment-ibs-c 2026-04-01T09:42:09+00:00 weekly 1 https://www.almirall.it/news/almirall-launches-eklirar-genuairr-aclidinium-europe 2026-04-01T09:42:09+00:00 weekly 1 https://www.almirall.it/news/almirall-obtains-rights-linaclotide-mexico 2026-04-01T09:42:11+00:00 weekly 1 https://www.almirall.it/news/almirall-opens-new-affiliate-canada 2026-04-01T09:42:11+00:00 weekly 1 https://www.almirall.it/news/eklirar-genuairr-provides-meaningful-and-sustained-bronchodilation-first-dose-patients-prefer 2026-04-01T09:42:12+00:00 weekly 1 https://www.almirall.it/news/almiralls-h1-strong-newsflow-and-guidance-reiterated 2026-04-01T09:42:12+00:00 weekly 1 https://www.almirall.it/news/eklirarbretarisr-genuairr-aclidinium-bromide-approved-europe-maintenance-treatment-chronic 2026-04-01T09:42:13+00:00 weekly 1 https://www.almirall.it/news/almirall-and-forest-laboratories-announce-fda-approval-tudorzatm-pressairtm-long-term 2026-04-01T09:42:13+00:00 weekly 1 https://www.almirall.it/news/que-medicamentos-tendran-nuestros-hijos-retos-para-equilibrar-investigacion-y-coste-sanitario 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/abediterol-almiralls-od-laba-shows-superiority-vs-indacaterol-phase-iia 2026-04-01T09:42:15+00:00 weekly 1 https://www.almirall.it/news/almiralls-aclidinium-recommended-approval-europe-treat-copd 2026-04-01T09:42:15+00:00 weekly 1 https://www.almirall.it/news/almirall-and-aslan-sign-global-agreement-novel-treatment-rheumatoid-arthritis 2026-04-01T09:42:16+00:00 weekly 1 https://www.almirall.it/news/sativexr-starts-third-phase-iii-clinical-trial-cancer-pain 2026-04-01T09:42:16+00:00 weekly 1 https://www.almirall.it/news/new-strategic-direction-almiralls-od-laba-following-successful-phase-iia-completion 2026-04-01T09:42:16+00:00 weekly 1 https://www.almirall.it/news/almirall-and-forest-present-aclidinium-bromide-clinical-data-american-thoracic-society-ats 2026-04-01T09:42:18+00:00 weekly 1 https://www.almirall.it/news/almirall-grows-internationally 2026-04-01T09:42:18+00:00 weekly 1 https://www.almirall.it/news/sativexr-mutual-recognition-procedure-closes-recommendation-approval-ten-european-countries 2026-04-01T09:42:18+00:00 weekly 1 https://www.almirall.it/news/almirall-annual-general-meeting-approves-018-euro-pay-out-share-scrip-dividend 2026-04-01T09:42:20+00:00 weekly 1 https://www.almirall.it/news/almirall-and-forest-laboratories-announce-fda-has-extended-review-period-aclidinium-bromide 2026-04-01T09:42:20+00:00 weekly 1 https://www.almirall.it/news/almirall-and-menarini-sign-licence-agreement-and-commercial-alliance-aclidinium-majority 2026-04-01T09:42:21+00:00 weekly 1 https://www.almirall.it/news/aclidinium-clinical-data-published-european-respiratory-journal-confirms-efficacy-and-safety 2026-04-01T09:42:21+00:00 weekly 1 https://www.almirall.it/news/el-tratamiento-personalizado-de-la-epoc-principal-reto-para-los-especialistas-only-available 2026-04-01T09:42:22+00:00 weekly 1 https://www.almirall.it/news/almirall-extends-sativexr-marketing-rights-mexico 2026-04-01T09:42:22+00:00 weekly 1 https://www.almirall.it/news/almirall-supports-european-post-graduate-clinical-research-ms-spasticity-two-annual-grants 2026-04-01T09:42:22+00:00 weekly 1 https://www.almirall.it/news/almirall-results-2011-line-positive-newsflow-start-2012 2026-04-01T09:42:24+00:00 weekly 1 https://www.almirall.it/news/almirall-and-forest-announce-positive-fda-advisory-committees-recommendation-approval 2026-04-01T09:42:24+00:00 weekly 1 https://www.almirall.it/news/la-vi-reunion-vam-presenta-las-nuevas-evidencias-en-el-tratamiento-de-las-enfermedades 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-licenses-aclidinium-daewoong-korea 2026-04-01T09:42:25+00:00 weekly 1 https://www.almirall.it/news/desciende-el-tabaquismo-pasivo-gracias-la-ley-antitabaco-y-se-mantiene-el-numero-de-fumadores 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/bayer-and-almirall-co-promote-anticoagulant-rivaroxaban-spain 2026-04-01T09:42:27+00:00 weekly 1 https://www.almirall.it/news/sativexr-starts-new-wave-regulatory-submissions-europe 2026-04-01T09:42:27+00:00 weekly 1 https://www.almirall.it/news/almirall-celebrates-10-years-mexico 2026-04-01T09:42:28+00:00 weekly 1 https://www.almirall.it/news/almirall-and-galapagos-enter-research-alliance 2026-04-01T09:42:28+00:00 weekly 1 https://www.almirall.it/news/almirall-colabora-con-la-fundacion-vicente-ferrer-en-un-proyecto-de-construccion-de-viviendas 2026-04-01T09:42:28+00:00 weekly 1 https://www.almirall.it/news/almirall-launches-solarazer-spain-treatment-actinic-keratosis 2026-04-01T09:42:30+00:00 weekly 1 https://www.almirall.it/news/almirall-starts-phase-iii-aclidinium-and-formoterol-copd 2026-04-01T09:42:30+00:00 weekly 1 https://www.almirall.it/news/almirall-and-biofocus-announce-collaboration-find-new-hit-compounds-against-key-targets 2026-04-01T09:42:30+00:00 weekly 1 https://www.almirall.it/news/almirall-colabora-con-la-sed-en-el-dia-mundial-de-la-diabetes-only-available-spanish 2026-04-01T09:42:31+00:00 weekly 1 https://www.almirall.it/news/mas-de-la-mitad-de-los-diabeticos-tipo-2-no-tiene-un-control-adecuado-de-la-enfermedad-only 2026-04-01T09:42:31+00:00 weekly 1 https://www.almirall.it/news/q3-results-almirall-prepares-future-growth 2026-04-01T09:42:33+00:00 weekly 1 https://www.almirall.it/news/8-de-cada-10-espanoles-no-sabe-que-es-la-epoc 2026-04-01T09:42:33+00:00 weekly 1 https://www.almirall.it/news/full-phase-iii-data-highlight-efficacy-and-tolerability-sativexr-therapy-treatment-spasticity 2026-04-01T09:42:34+00:00 weekly 1 https://www.almirall.it/news/linaclotide-provides-long-term-relief-symptoms-irritable-bowel-syndrome-constipation 2026-04-01T09:42:34+00:00 weekly 1 https://www.almirall.it/news/almirall-and-lundbeck-announce-co-promotion-agreement-escitalopram-italy 2026-04-01T09:42:35+00:00 weekly 1 https://www.almirall.it/news/almirall-and-spanish-pharmacological-society-recognise-research-diabetes 2026-04-01T09:42:35+00:00 weekly 1 https://www.almirall.it/news/almirall-launches-roflumilast-spain 2026-04-01T09:42:36+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-regulatory-filing-linaclotide-treatment-irritable-bowel-syndrome 2026-04-01T09:42:36+00:00 weekly 1 https://www.almirall.it/news/almirall-and-nycomed-announce-licensing-agreement-ebastine-china-and-other-key-southeast-asia 2026-04-01T09:42:36+00:00 weekly 1 https://www.almirall.it/news/una-nueva-guia-ayudara-los-medicos-en-el-manejo-de-la-osteoporosis-postmenopausica 2026-04-01T09:42:38+00:00 weekly 1 https://www.almirall.it/news/copd-patients-experienced-benefits-first-dose-when-treated-aclidinium-shown-attain-phase-iii 2026-04-01T09:42:38+00:00 weekly 1 https://www.almirall.it/news/almirall-enters-integrated-discovery-agreement-proteros 2026-04-01T09:42:38+00:00 weekly 1 https://www.almirall.it/news/almirall-appoints-alfredo-baron-area-director-southern-and-eastern-europe 2026-04-01T09:42:39+00:00 weekly 1 https://www.almirall.it/news/almirall-h1-financial-results 2026-04-01T09:42:39+00:00 weekly 1 https://www.almirall.it/news/aclidinium-bromide-submitted-registration-europe 2026-04-01T09:42:39+00:00 weekly 1 https://www.almirall.it/news/almirall-strengthens-its-german-business-two-new-products-sativexr-and-actikerallr 2026-04-01T09:42:41+00:00 weekly 1 https://www.almirall.it/news/farid-taha-new-general-manager-almirall-germany-austria-and-switzerland 2026-04-01T09:42:41+00:00 weekly 1 https://www.almirall.it/news/almirall-and-forest-announce-regulatory-submission-aclidinium-bromide-treatment-copd-usa 2026-04-01T09:42:41+00:00 weekly 1 https://www.almirall.it/news/nuevos-datos-avalan-la-seguridad-y-la-eficacia-del-bazedoxifeno-para-prevenir-fracturas 2026-04-01T09:42:43+00:00 weekly 1 https://www.almirall.it/news/almirall-empresa-comprometida-con-la-formacion-de-los-gestores-sanitarios 2026-04-01T09:42:43+00:00 weekly 1 https://www.almirall.it/news/la-sepd-en-colaboracion-con-almirall-presenta-el-libro-el-paciente-con-sintomas-digestivos 2026-04-01T09:42:43+00:00 weekly 1 https://www.almirall.it/news/sativexr-approved-denmark-treatment-spasticity-due-multiple-sclerosis-ms 2026-04-01T09:42:45+00:00 weekly 1 https://www.almirall.it/news/actikerallr-launched-uk-treatment-actinic-keratosis-including-grade-i-and-ii-severity 2026-04-01T09:42:45+00:00 weekly 1 https://www.almirall.it/news/daniel-martinez-carretero-appointed-chief-financial-officer-cfo-almirall 2026-04-01T09:42:47+00:00 weekly 1 https://www.almirall.it/news/almirall-strengthens-their-ongoing-commitment-patients-multiple-sclerosis-through-their 2026-04-01T09:42:47+00:00 weekly 1 https://www.almirall.it/news/sativexr-approved-germany-treatment-spasticity-due-multiple-sclerosis 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-q1-financial-results-line-attain-yearly-guidance 2026-04-01T09:42:49+00:00 weekly 1 https://www.almirall.it/news/almiralls-annual-general-meeting-approves-dividend-029-euros-share 2026-04-01T09:42:49+00:00 weekly 1 https://www.almirall.it/news/almirall-and-forest-present-data-phase-iii-studies-aclidinium-bromide-chronic-obstructive 2026-04-01T09:42:49+00:00 weekly 1 https://www.almirall.it/news/regulators-confirm-actikerallr-treatment-actinic-keratoses-including-grade-i-and-ii-approvable 2026-04-01T09:42:51+00:00 weekly 1 https://www.almirall.it/news/almirall-and-nycomed-announce-commercialization-agreement-roflumilast-spain 2026-04-01T09:42:51+00:00 weekly 1 https://www.almirall.it/news/el-tabaquismo-es-la-enfermedad-respiratoria-mas-frecuente 2026-04-01T09:42:53+00:00 weekly 1 https://www.almirall.it/news/almirall-strengthens-its-respiratory-franchise-new-generation-chronic-obstructive-pulmonary 2026-04-01T09:42:53+00:00 weekly 1 https://www.almirall.it/news/almirall-apuesta-por-la-formacion-gestores-sanitarios-en-un-modelo-efectivo-de-liderazgo 2026-04-01T09:42:53+00:00 weekly 1 https://www.almirall.it/news/almirall-meets-guidance-2025-delivering-124-net-sales-growth-and-further-pipeline-progress 2026-04-01T09:33:55+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-lumine-phase-iii-clinical-study-assessing-efficacy-lebrikizumab-treatment 2026-04-01T13:10:01+00:00 weekly 1 https://www.almirall.it/news/almiralls-immunoskin-gathers-leading-experts-advance-science-and-treatment-inflammatory-skin 2026-04-01T13:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-continues-its-sustained-growth-trajectory-9m-2025-delivering-128-net-sales-growth 2026-04-01T09:34:00+00:00 weekly 1 https://www.almirall.it/news/almirall-presents-long-term-results-first-real-world-dermatology-study-using-who-5-well-being 2026-04-01T09:34:00+00:00 weekly 1 https://www.almirall.it/news/eadv-2025-almirall-advances-skin-science-and-leads-innovation-holistic-patient-care-medical 2026-04-01T09:34:02+00:00 weekly 1 https://www.almirall.it/news/almirall-and-absci-expand-ai-drug-creation-collaboration-adding-second-dermatology-target 2026-04-01T09:34:02+00:00 weekly 1 https://www.almirall.it/news/almirall-h1-2025-results-almirall-continues-deliver-its-long-term-growth-strategy-net-sales 2026-04-01T09:34:03+00:00 weekly 1 https://www.almirall.it/news/almirall-shows-efficacy-biologics-real-world-evidence-and-new-patient-centric-research 2026-04-01T09:34:03+00:00 weekly 1 https://www.almirall.it/news/almirall-leads-paradigm-shift-holistic-patient-care-dermatology-applying-who-5-well-being 2026-04-01T09:34:04+00:00 weekly 1 https://www.almirall.it/news/almirall-delivers-strong-start-2025-growing-q1-overall-sales-15-and-234-its-european 2026-04-01T09:34:04+00:00 weekly 1 https://www.almirall.it/news/almirall-and-biofrontera-launch-hats-challenge-raise-awareness-and-support-actinic-keratosis 2026-04-01T09:34:06+00:00 weekly 1 https://www.almirall.it/news/almiralls-16th-skin-academy-brings-together-leading-experts-advance-skin-science-and-treatment 2026-04-01T09:34:06+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-cfo-transition-plan-and-appoints-jon-u-garay-alonso-cfo-succeed-mike 2026-04-01T09:34:07+00:00 weekly 1 https://www.almirall.it/news/almirall-surpassed-guidance-2024-entering-era-sustained-growth-and-further-advancing-its 2026-04-01T09:34:07+00:00 weekly 1 https://www.almirall.it/news/almirall-jpmorgan-conference-entering-new-era-sustained-growth 2026-04-01T09:34:08+00:00 weekly 1 https://www.almirall.it/news/almirall-launches-almirall-innovation-hub-hive-creating-novel-collaborative-innovation-hub 2026-04-01T09:34:08+00:00 weekly 1 https://www.almirall.it/news/almiralls-nine-month-2024-results-almirall-reports-strong-performance-q3-2024-driven 2026-04-01T09:34:10+00:00 weekly 1 https://www.almirall.it/news/almirall-launches-campaign-me-my-inner-circle-acknowledge-vital-role-friends-and-family-people 2026-04-01T09:34:10+00:00 weekly 1 https://www.almirall.it/news/almiralls-2024-immunoskin-conference-hosts-leading-experts-inflammatory-skin-conditions 2026-04-01T09:34:11+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-completion-decentralized-regulatory-approval-procedure-efinaconazole-europe 2026-04-01T09:34:11+00:00 weekly 1 https://www.almirall.it/news/new-data-show-almiralls-ebglyssr-lebrikizumab-provided-sustained-disease-control-three-years 2026-04-01T09:34:12+00:00 weekly 1 https://www.almirall.it/news/33rd-congress-european-academy-dermatology-and-venereology-eadv 2026-04-01T09:34:12+00:00 weekly 1 https://www.almirall.it/news/14th-september-world-atopic-eczema-day 2026-04-01T09:34:14+00:00 weekly 1 https://www.almirall.it/news/almiralls-h1-2024-results 2026-04-01T09:34:14+00:00 weekly 1 https://www.almirall.it/news/nice-recommends-ebglyss-lebrikizumab-use-moderate-severe-atopic-dermatitis-nhs-england 2026-04-01T09:34:15+00:00 weekly 1 https://www.almirall.it/news/almirall-launches-act4impact-its-updated-sustainability-strategy-setting-ambitious-targets 2026-04-01T09:34:15+00:00 weekly 1 https://www.almirall.it/news/almiralls-ilumetrir-tildrakizumab-demonstrates-high-rates-skin-clearance-and-sustained 2026-04-01T09:34:16+00:00 weekly 1 https://www.almirall.it/news/fda-approves-almiralls-klisyrir-tirbanibulin-treatment-actinic-keratosis-expanded-area-face-or 2026-04-01T09:34:16+00:00 weekly 1 https://www.almirall.it/news/ebglyssr-lebrikizumab-ranked-number-one-interleukin-inhibitors-severe-atopic-dermatitis-adults 2026-04-01T09:34:17+00:00 weekly 1 https://www.almirall.it/news/may-24th-actinic-keratosis-ak-global-day 2026-04-01T09:34:17+00:00 weekly 1 https://www.almirall.it/news/almiralls-q1-2024-results-almirall-delivers-strong-start-2024-q1-net-sales-growth-66-overall 2026-04-01T09:34:19+00:00 weekly 1 https://www.almirall.it/news/almirall-licenses-anti-il-21-monoclonal-antibody-novo-nordisk-develop-it-first-class-agent 2026-04-01T09:34:20+00:00 weekly 1 https://www.almirall.it/news/almirall-receives-rating-cdp-its-contributions-fight-against-climate-change 2026-04-01T09:34:20+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-partnership-centre-genomic-regulation-crg-identify-biomarkers-novel-atopic 2026-04-01T09:34:21+00:00 weekly 1 https://www.almirall.it/news/almirall-and-microsoft-announce-partnership-digital-transformation-enable-development-novel 2026-04-01T09:34:21+00:00 weekly 1 https://www.almirall.it/news/almirall-initiates-first-phase-i-clinical-study-alm223-interleukin-2-mutant-fusion-protein 2026-04-01T09:34:21+00:00 weekly 1 https://www.almirall.it/news/almirall-participate-42nd-annual-jp-morgan-healthcare-conference 2026-04-01T09:34:23+00:00 weekly 1 https://www.almirall.it/news/almirall-and-etherna-enter-multi-target-alliance-develop-mrna-based-therapies-medical 2026-04-01T09:34:23+00:00 weekly 1 https://www.almirall.it/news/almirall-barcelona-supercomputing-center-bsc-and-nostrum-biodiscovery-collaborate-seek-new 2026-04-01T09:34:24+00:00 weekly 1 https://www.almirall.it/news/almirall-receives-european-commission-approval-ebglyssr-lebrikizumab-moderate-severe-atopic 2026-04-01T09:34:24+00:00 weekly 1 https://www.almirall.it/news/almirall-and-absci-announce-ai-drug-discovery-partnership-rapidly-develop-novel-treatments 2026-04-01T09:34:26+00:00 weekly 1 https://www.almirall.it/news/almirall-achieves-net-sales-growth-64-driven-strong-european-dermatology-performance 2026-04-01T09:34:26+00:00 weekly 1 https://www.almirall.it/news/psoriasis-was-found-impact-wellbeing-similar-level-breast-cancer 2026-04-01T09:34:27+00:00 weekly 1 https://www.almirall.it/news/almirall-opens-new-call-proposals-better-understand-key-pathological-mechanisms-several-skin 2026-04-01T09:34:27+00:00 weekly 1 https://www.almirall.it/news/almirall-nearly-80-patients-moderate-severe-atopic-dermatitis-maintained-clear-or-almost-clear 2026-04-01T09:34:28+00:00 weekly 1 https://www.almirall.it/news/almiralls-lebrikizumab-improves-signs-and-symptoms-moderate-severe-atopic-dermatitis-ad 2026-04-01T09:34:28+00:00 weekly 1 https://www.almirall.it/news/epimab-biotherapeutics-and-almirall-announce-bispecific-antibody-license-agreement 2026-04-01T13:10:01+00:00 weekly 1 https://www.almirall.it/news/almiralls-ilumetrir-tildrakizumab-significantly-improves-wellbeing-patients-and-their 2026-04-01T09:34:30+00:00 weekly 1 https://www.almirall.it/news/centrient-pharmaceuticals-joins-almiralls-growing-innovation-hub-barcelona 2026-04-01T09:34:31+00:00 weekly 1 https://www.almirall.it/news/ebglyssr-lebrikizumab-receives-positive-chmp-opinion-moderate-severe-atopic-dermatitis 2026-04-01T09:34:31+00:00 weekly 1 https://www.almirall.it/news/moving-ahead-almirall-message-raise-awareness-about-atopic-eczema 2026-04-01T09:34:31+00:00 weekly 1 https://www.almirall.it/news/almirall-achieves-net-sales-growth-7-eu4661mm-driven-strong-growth-european-dermatology 2026-04-01T09:34:33+00:00 weekly 1 https://www.almirall.it/news/science-based-targets-initiative-sbti-validates-almiralls-2030-emission-reduction-targets-and 2026-04-01T09:34:33+00:00 weekly 1 https://www.almirall.it/news/almirall-ilumetrir-tildrakizumab-significantly-improved-wellbeing-patients-moderate-severe 2026-04-01T09:34:34+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-pricing-and-closing-its-eu200mm-non-pre-emptive-share-capital-increase 2026-04-01T09:34:34+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-launch-eu200mm-non-pre-emptive-share-capital-increase 2026-04-01T09:34:34+00:00 weekly 1 https://www.almirall.it/news/almirall-launches-nina-first-series-highlight-major-impact-psoriasis-patients-wellbeing 2026-04-01T09:34:35+00:00 weekly 1 https://www.almirall.it/news/almirall-and-centre-genomic-regulation-crg-collaborate-develop-and-characterize-novel 2026-04-01T09:34:35+00:00 weekly 1 https://www.almirall.it/news/85-people-unaware-actinic-keratosis-most-common-pre-cancerous-skin-condition 2026-04-01T09:34:35+00:00 weekly 1 https://www.almirall.it/news/almiralls-net-sales-reach-eu-232mm-and-increase-6-boosted-solid-european-dermatology-business 2026-04-01T09:34:37+00:00 weekly 1 https://www.almirall.it/news/almirall-73-atopic-dermatitis-patients-taking-lebrikizumab-had-improved-or-cleared-skin-face 2026-04-01T09:34:37+00:00 weekly 1 https://www.almirall.it/news/almirall-first-assess-wellbeing-dermatology-clinical-study 2026-04-01T09:34:37+00:00 weekly 1 https://www.almirall.it/news/almirall-new-england-journal-medicine-nejm-and-british-journal-dermatology-bjd-publish-ph3 2026-04-01T09:34:39+00:00 weekly 1 https://www.almirall.it/news/almiralls-full-year-2022-results-almirall-closes-2022-core-net-sales-growth-66-driven-its 2026-04-01T09:34:40+00:00 weekly 1 https://www.almirall.it/news/almirall-participate-41st-annual-jp-morgan-healthcare-conference 2026-04-01T09:34:40+00:00 weekly 1 https://www.almirall.it/news/almirall-appoints-mercedes-diz-vp-corporate-strategy 2026-04-01T09:34:41+00:00 weekly 1 https://www.almirall.it/news/almirall-joins-facilitate-patient-driven-innovative-medicines-initiative-imi-project-enable 2026-04-01T09:34:41+00:00 weekly 1 https://www.almirall.it/news/almiralls-nine-month-2022-results-almirall-achieves-core-net-sales-eu6338-mm-euros-first-nine 2026-04-01T09:34:41+00:00 weekly 1 https://www.almirall.it/news/almirall-opens-new-subsidiary-czech-republic-and-slovakia 2026-04-01T09:34:43+00:00 weekly 1 https://www.almirall.it/news/almiralls-chairman-carlos-gallardo-appointed-interim-ceo 2026-04-01T09:34:43+00:00 weekly 1 https://www.almirall.it/news/almiralls-shedding-light-psoriasis-campaign-exposes-impact-disease-mental-health-and-wellbeing 2026-04-01T09:34:43+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-ema-acceptance-filing-marketing-authorization-application-maa-lebrikizumab 2026-04-01T09:34:44+00:00 weekly 1 https://www.almirall.it/news/almirall-partners-chemical-institute-sarria-iqs-bring-pharmacy-students-training-closer-real 2026-04-01T09:34:44+00:00 weekly 1 https://www.almirall.it/news/almirall-and-simcere-enter-licensing-agreement-il-2-mu-fc 2026-04-01T09:34:44+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-initiation-phase-i-study-anti-il-1rap-first-class-monoclonal-antibody 2026-04-01T09:34:46+00:00 weekly 1 https://www.almirall.it/news/almirall-lebrikizumab-dosed-every-four-weeks-maintained-durable-skin-clearance-phase-3 2026-04-01T09:34:46+00:00 weekly 1 https://www.almirall.it/news/almirall-lebrikizumabs-52-week-late-breaking-data-will-be-presented-31st-european-academy 2026-04-01T09:34:47+00:00 weekly 1 https://www.almirall.it/news/almiralls-h1-2022-results 2026-04-01T09:34:47+00:00 weekly 1 https://www.almirall.it/news/almirall-launches-new-call-find-innovative-therapies-skin-diseases 2026-04-01T09:34:47+00:00 weekly 1 https://www.almirall.it/news/happify-health-and-almirall-go-live-digital-solution-support-psoriasis-patients 2026-04-01T09:34:48+00:00 weekly 1 https://www.almirall.it/news/almirall-eight-out-ten-patients-maintained-skin-clearance-one-year-lebrikizumab-atopic 2026-04-01T09:34:48+00:00 weekly 1 https://www.almirall.it/news/almirall-initiates-decentralised-procedure-europe-treatment-mild-moderate-fungal-nail 2026-04-01T09:34:48+00:00 weekly 1 https://www.almirall.it/news/almirall-launches-innovative-wynzorar-cream-denmark-treatment-mild-moderate-plaque-psoriasis 2026-04-01T09:34:50+00:00 weekly 1 https://www.almirall.it/news/almirall-launches-actinic-keratosis-ak-global-day-during-skin-cancer-awareness-month 2026-04-01T09:34:50+00:00 weekly 1 https://www.almirall.it/news/almirall-and-happify-health-go-live-digital-therapeutics-support-psoriasis-patients 2026-04-01T09:34:50+00:00 weekly 1 https://www.almirall.it/news/almirall-and-evotec-enter-multi-target-alliance-medical-dermatology 2026-04-01T09:34:51+00:00 weekly 1 https://www.almirall.it/news/almirall-and-inserm-transfert-enter-licensing-and-research-collaboration-develop-innovative 2026-04-01T09:34:51+00:00 weekly 1 https://www.almirall.it/news/almirall-delivers-good-business-performance-q1-and-reiterates-full-year-2022-guidance 2026-04-01T09:34:51+00:00 weekly 1 https://www.almirall.it/news/carlos-gallardo-asume-la-presidencia-de-almirall 2026-04-01T09:34:53+00:00 weekly 1 https://www.almirall.it/news/almirall-lebrikizumab-combined-topical-corticosteroids-showed-significant-improvements-disease 2026-04-01T09:34:53+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-new-research-collaboration-university-dundee-develop-innovative-and 2026-04-01T09:34:54+00:00 weekly 1 https://www.almirall.it/news/almirall-majority-patients-treated-lebrikizumab-achieved-skin-clearance-pivotal-phase-3-atopic 2026-04-01T09:34:54+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-collaboration-university-michigan-gain-understanding-disease-drivers 2026-04-01T09:34:55+00:00 weekly 1 https://www.almirall.it/news/dr-jorge-gallardo-ballart-announces-his-intention-retire-his-positions-president-board 2026-04-01T09:34:55+00:00 weekly 1 https://www.almirall.it/news/almiralls-full-year-2021-results 2026-04-01T09:34:55+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-multi-target-licensing-agreement-ablexis-and-collaboration-alivamab 2026-04-01T09:34:59+00:00 weekly 1 https://www.almirall.it/news/almirall-and-irb-barcelona-announce-research-collaboration-discover-novel-molecular-glue 2026-04-01T09:34:59+00:00 weekly 1 https://www.almirall.it/news/almirall-lebrikizumab-demonstrated-significant-skin-improvement-and-itch-relief-when-combined 2026-04-01T09:34:59+00:00 weekly 1 https://www.almirall.it/news/hoy-si-me-puedo-levantar-campaign-support-people-living-multiple-sclerosis-ms 2026-04-01T09:35:01+00:00 weekly 1 https://www.almirall.it/news/ichnos-sciences-and-almirall-enter-licensing-agreement-first-class-il-1rap-antagonist 2026-04-01T09:35:01+00:00 weekly 1 https://www.almirall.it/news/almirall-delivers-solid-nine-months-2021-results-and-tightens-its-upgraded-guidance 2026-04-01T09:35:02+00:00 weekly 1 https://www.almirall.it/news/almirall-launches-shedding-light-psoriasis-campaign-raise-awareness-world-psoriasis-day 2026-04-01T09:35:02+00:00 weekly 1 https://www.almirall.it/news/almiralls-roadmap-more-sustainable-future 2026-04-01T09:35:02+00:00 weekly 1 https://www.almirall.it/news/experts-highlight-need-focus-psoriasis-patients-wellbeing-clinical-practice 2026-04-01T13:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-launches-klisyrirvtirbanibulin-treatment-actinic-keratosis-europe 2026-04-01T13:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-pricing-eu300-million-issuance-senior-notes-due-2026 2026-04-01T09:35:03+00:00 weekly 1 https://www.almirall.it/news/lebrikizumab-significantly-improved-skin-clearance-and-itch-people-moderate-severe-atopic 2026-04-01T09:35:05+00:00 weekly 1 https://www.almirall.it/news/almirall-delivers-robust-h1-performance-and-increases-full-year-guidance 2026-04-01T09:35:05+00:00 weekly 1 https://www.almirall.it/news/almirall-receives-european-commission-approval-klisyrir-v-tirbanibulin-innovative-topical 2026-04-01T09:35:06+00:00 weekly 1 https://www.almirall.it/news/almirall-and-mc2-therapeutics-announce-completion-decentralized-procedure-europe-topical 2026-04-01T09:35:06+00:00 weekly 1 https://www.almirall.it/news/almirall-launches-new-call-establish-partnerships-innovative-therapies-skin-diseases 2026-04-01T09:35:06+00:00 weekly 1 https://www.almirall.it/news/almirall-and-kaken-pharmaceutical-enter-license-and-distribution-agreement-european-rights 2026-04-01T09:35:08+00:00 weekly 1 https://www.almirall.it/news/almirall-joins-biomap-new-partner-advance-field-inflammatory-skin-conditions 2026-04-01T09:35:08+00:00 weekly 1 https://www.almirall.it/news/almirall-appoints-dr-karl-ziegelbauer-chief-scientific-officer 2026-04-01T09:35:08+00:00 weekly 1 https://www.almirall.it/news/almirall-receives-fda-approval-produce-seysara-r-sarecycline-sant-andreu-de-la-barca-barcelona 2026-04-01T09:35:10+00:00 weekly 1 https://www.almirall.it/news/almirall-receives-positive-chmp-opinion-klisyrirv-tirbanibulin-innovative-topical-treatment 2026-04-01T09:35:10+00:00 weekly 1 https://www.almirall.it/news/almiralls-solid-core-business-q1-performance-boosted-growth-drivers-momentum 2026-04-01T09:35:11+00:00 weekly 1 https://www.almirall.it/news/almirall-proposes-ruud-dobber-new-member-its-board-directors 2026-04-01T09:35:11+00:00 weekly 1 https://www.almirall.it/news/almirall-receives-qualification-excellent-profarma-2020-program 2026-04-01T09:35:11+00:00 weekly 1 https://www.almirall.it/news/almiralls-2020-full-year-results 2026-04-01T09:35:12+00:00 weekly 1 https://www.almirall.it/news/almirall-and-mc2-therapeutics-enter-license-collaboration-and-commercialization-agreement 2026-04-01T09:35:12+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-new-england-journal-medicine-publication-phase-iii-data-demonstrating 2026-04-01T09:35:14+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-new-publication-british-journal-dermatology-ilumetrirv-tildrakizumab-first 2026-04-01T09:35:14+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-gianfranco-nazzi-new-ceo 2026-04-01T09:35:15+00:00 weekly 1 https://www.almirall.it/news/almirall-and-happify-health-enter-strategic-partnership-develop-evidence-supported-digital 2026-04-01T09:35:15+00:00 weekly 1 https://www.almirall.it/news/cdp-recognizes-almirall-its-commitment-fight-against-climate-change 2026-04-01T09:35:15+00:00 weekly 1 https://www.almirall.it/news/almirall-and-tyris-therapeutics-enter-strategic-partnership-develop-next-generation-gene 2026-04-01T09:35:16+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-fda-approval-klisyrir-tirbanibulin-new-innovative-topical-treatment-actinic 2026-04-01T09:35:16+00:00 weekly 1 https://www.almirall.it/news/almirall-has-selected-six-digital-health-start-ups-join-second-harvest-digital-garden 2026-04-01T09:35:18+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-collaborations-university-south-australia-and-fundacio-institut-de-recerca 2026-04-01T09:35:18+00:00 weekly 1 https://www.almirall.it/news/popit-and-almirall-start-offering-new-support-tool-help-psoriasis-patients 2026-04-01T09:35:19+00:00 weekly 1 https://www.almirall.it/news/pablo-alvarez-appointed-president-and-gm-almirall-us 2026-04-01T09:35:19+00:00 weekly 1 https://www.almirall.it/news/almirall-demonstrates-resilient-performance-year-date-despite-covid-19-impacts 2026-04-01T09:35:20+00:00 weekly 1 https://www.almirall.it/news/board-directors-nominates-carlos-gallardo-vice-president-board 2026-04-01T09:35:20+00:00 weekly 1 https://www.almirall.it/news/first-complete-dataset-il-23p19-class-demonstrates-ilumetrirv-tildrakizumab-long-term-efficacy 2026-04-01T09:35:22+00:00 weekly 1 https://www.almirall.it/news/almirall-launches-its-second-innovation-initiative-dermatology-focused-digital-health-start 2026-04-01T09:35:22+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-approval-reimbursed-price-ilumetrirtildrakizumab-france-treatment-adult 2026-04-01T09:35:23+00:00 weekly 1 https://www.almirall.it/news/almirall-and-university-dundee-announce-multi-target-research-collaboration-develop-novel 2026-04-01T09:35:23+00:00 weekly 1 https://www.almirall.it/news/ceo-peter-guenter-leave-almirall-31122020-pursue-new-opportunities 2026-04-01T09:35:23+00:00 weekly 1 https://www.almirall.it/news/sustained-performance-key-growth-drivers-and-excellent-progress-pipeline-h1-despite-negative 2026-04-01T09:35:25+00:00 weekly 1 https://www.almirall.it/news/almirall-calls-collaborative-innovation-advance-new-treatments-skin-diseases 2026-04-01T09:35:25+00:00 weekly 1 https://www.almirall.it/news/almirall-joins-amr-action-fund-support-fight-against-antimicrobial-resistance 2026-04-01T09:35:26+00:00 weekly 1 https://www.almirall.it/news/almirall-enters-ibex-35 2026-04-01T09:35:26+00:00 weekly 1 https://www.almirall.it/news/almirall-e-ms-experts-summit-season-2020 2026-04-01T09:35:27+00:00 weekly 1 https://www.almirall.it/news/almirall-uc3m-and-medina-foundation-research-new-treatments-rare-genetic-diseases 2026-04-01T09:35:27+00:00 weekly 1 https://www.almirall.it/news/solid-q1-2020-performance 2026-04-01T09:35:27+00:00 weekly 1 https://www.almirall.it/news/almirall-ensure-business-continuity-all-drugs-essential-patients 2026-04-01T09:35:29+00:00 weekly 1 https://www.almirall.it/news/almirall-announcement 2026-04-01T09:35:29+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-fda-acceptance-filing-us-new-drug-application-nda-tirbanibulin-actinic 2026-04-01T09:35:31+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-ema-acceptance-filing-marketing-authorization-application-maa-tirbanibulin 2026-04-01T09:35:31+00:00 weekly 1 https://www.almirall.it/news/almiralls-full-year-2019-results-strong-operational-performance-excellent-pipeline-progress 2026-04-01T09:35:31+00:00 weekly 1 https://www.almirall.it/news/almirall-and-paratek-enter-license-agreement-seysarar-china 2026-04-01T09:35:33+00:00 weekly 1 https://www.almirall.it/news/almirall-partners-plug-and-play-accelerate-digital-innovation-dermatology 2026-04-01T09:35:33+00:00 weekly 1 https://www.almirall.it/news/almirall-participate-jp-morgan-healthcare-conference-san-francisco 2026-04-01T09:35:33+00:00 weekly 1 https://www.almirall.it/news/almirall-signs-strategic-agreement-23andme-license-rights-bispecific-monoclonal-antibody 2026-04-01T09:35:35+00:00 weekly 1 https://www.almirall.it/news/almirall-and-wuxi-biologics-sign-strategic-collaboration-agreement-multiple-bispecific 2026-04-01T09:35:35+00:00 weekly 1 https://www.almirall.it/news/almirall-enters-option-agreement-acquire-bioniz-therapeutics-and-establish-broad-research 2026-04-01T09:35:35+00:00 weekly 1 https://www.almirall.it/news/almirallshare-responsible-50-private-public-collaborations-almirall 2026-04-01T09:35:37+00:00 weekly 1 https://www.almirall.it/news/almirall-and-iktos-announce-research-collaboration-artificial-intelligence-new-drug-design 2026-04-01T09:35:37+00:00 weekly 1 https://www.almirall.it/news/volker-koscielny-new-chief-medical-officer-and-new-member-management-board-almirall 2026-04-01T09:35:37+00:00 weekly 1 https://www.almirall.it/news/almirall-launches-accelerator-digital-garden-drive-digital-innovation-dermatology 2026-04-01T09:35:38+00:00 weekly 1 https://www.almirall.it/news/majority-shareholders-almirall-give-mandate-increase-free-float 2026-04-01T09:35:38+00:00 weekly 1 https://www.almirall.it/news/almirall-llc-announces-publication-long-term-safety-data-use-seysarar-sarecycline-tablets 2026-04-01T09:35:38+00:00 weekly 1 https://www.almirall.it/news/almirall-9m-2019-business-results-continued-good-business-momentum-driven-positive-uptake 2026-04-01T09:35:40+00:00 weekly 1 https://www.almirall.it/news/duaklirr-will-be-available-united-states-21st-october 2026-04-01T09:35:40+00:00 weekly 1 https://www.almirall.it/news/tildrakizumab-confirms-its-long-term-efficacy-and-safety-longest-il23p19-data-available 2026-04-01T09:35:41+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-initiation-phase-3-program-evaluating-lebrikizumab-patients-moderate-severe 2026-04-01T09:35:41+00:00 weekly 1 https://www.almirall.it/news/almirall-takes-leap-dermatology-digital-health-innovation 2026-04-01T09:35:41+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-cfo-leadership-transition-mike-mcclellan-join-almirall-november-11-new 2026-04-01T09:35:43+00:00 weekly 1 https://www.almirall.it/news/scottish-medicines-consortium-smc-provisionally-approves-almiralls-ilumetrirv-tildrakizumab 2026-04-01T09:35:43+00:00 weekly 1 https://www.almirall.it/news/almirall-h1-2019-continued-strong-business-momentum-while-reinforcing-pipeline 2026-04-01T09:35:43+00:00 weekly 1 https://www.almirall.it/news/almirall-calls-partners-develop-new-immune-dermatology-therapies 2026-04-01T09:35:44+00:00 weekly 1 https://www.almirall.it/news/almirall-revalidates-its-excellence-occupational-health-and-safety-environment-and-energy 2026-04-01T09:35:44+00:00 weekly 1 https://www.almirall.it/news/almirall-exercises-its-option-dermira-license-rights-lebrikizumab-europe-atopic-dermatitis 2026-04-01T09:35:44+00:00 weekly 1 https://www.almirall.it/news/investment-plan-europe-eib-finances-almiralls-research-new-skin-disease-treatments 2026-04-01T09:35:46+00:00 weekly 1 https://www.almirall.it/news/almirall-q1-2019-strong-operating-performance 2026-04-01T09:35:46+00:00 weekly 1 https://www.almirall.it/news/nice-publishes-final-recommendation-almiralls-ilumetrirv-tildrakizumab-cost-effective-option 2026-04-01T09:35:47+00:00 weekly 1 https://www.almirall.it/news/almirall-excellent-company-according-profarma-plan-ministry-industry-tourism-and-commerce 2026-04-01T09:44:42+00:00 weekly 1 https://www.almirall.it/news/ignasi-marti-rague-director-institutional-relations-almirall 2026-04-01T09:44:42+00:00 weekly 1 https://www.almirall.it/news/sativexr-mutual-recognition-procedure-closes-recommendation-approval-all-six-european 2026-04-01T09:44:42+00:00 weekly 1 https://www.almirall.it/news/lanzamiento-balneum-intensive-espana 2026-04-01T09:44:44+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-appointment-eduardo-sanchiz-new-ceo-july-1st-2011 2026-04-01T09:44:44+00:00 weekly 1 https://www.almirall.it/news/sativexr-launched-spain-treat-spasticity 2026-04-01T09:44:45+00:00 weekly 1 https://www.almirall.it/news/almirall-2010-financial-results-line-guidance 2026-04-01T09:44:45+00:00 weekly 1 https://www.almirall.it/news/almirall-and-kyorin-announce-licensing-agreement-japan-aclidinium-bromide 2026-04-01T09:44:45+00:00 weekly 1 https://www.almirall.it/news/almirall-appoints-eloi-crespo-new-general-director-industrial-area 2026-04-01T09:44:47+00:00 weekly 1 https://www.almirall.it/news/el-manejo-precoz-del-paciente-diabetico-clave-para-conseguir-una-prevencion-vascular-eficiente 2026-04-01T09:44:47+00:00 weekly 1 https://www.almirall.it/news/sativex-granted-reimbursement-spain-treatment-spasticity-multiple-sclerosis 2026-04-01T09:44:47+00:00 weekly 1 https://www.almirall.it/news/almirall-mexico-receives-distinction-companies-transparent-practices 2026-04-01T09:44:48+00:00 weekly 1 https://www.almirall.it/news/los-ultimos-avances-debate-en-el-x-symposium-de-psiquiatria-organizado-por-almirall 2026-04-01T09:44:48+00:00 weekly 1 https://www.almirall.it/news/almirall-and-forest-announce-positive-results-attain-phase-iii-study-aclidinium-bromide-and 2026-04-01T09:44:49+00:00 weekly 1 https://www.almirall.it/news/sativexr-enters-phase-iii-clinical-programme-oncological-pain 2026-04-01T09:44:51+00:00 weekly 1 https://www.almirall.it/news/almirall-and-ironwood-announce-positive-results-second-phase-iii-trial-linaclotide-patients 2026-04-01T09:44:52+00:00 weekly 1 https://www.almirall.it/news/almirall-and-forest-report-preliminary-topline-results-accord-copd-ii-phase-iii-study 2026-04-01T09:44:52+00:00 weekly 1 https://www.almirall.it/news/almirall-apoya-el-programa-de-actividades-puesto-en-marcha-por-la-sed-y-su-fundacion-para-el 2026-04-01T09:44:54+00:00 weekly 1 https://www.almirall.it/news/sativexr-data-presented-ectrims-congress-highlights-its-efficacy-add-therapy-treatment 2026-04-01T09:44:54+00:00 weekly 1 https://www.almirall.it/news/almirall-pioneer-obtaining-ohsas-18001-occupational-health-and-safety-renews-certificate 2026-04-01T09:44:55+00:00 weekly 1 https://www.almirall.it/news/launch-spain-urorecrsilodyxtm-new-treatment-symptoms-associated-benign-prostatic-hyperplasia 2026-04-01T09:44:55+00:00 weekly 1 https://www.almirall.it/news/conbrizar-bazedoxifene-approved-spanish-agency-medicines-and-healthcare-products-aemps 2026-04-01T09:44:55+00:00 weekly 1 https://www.almirall.it/news/research-chronic-pain-winning-project-pharmacology-award-presented-almirall-and-spanish 2026-04-01T09:44:57+00:00 weekly 1 https://www.almirall.it/news/almirall-receives-company-rating-excellent-ministry-industry-tourism-and-trade 2026-04-01T09:44:57+00:00 weekly 1 https://www.almirall.it/news/almirall-and-ironwood-announce-positive-results-phase-3-trial-linaclotide-patients-irritable 2026-04-01T09:44:58+00:00 weekly 1 https://www.almirall.it/news/almirall-awarded-zero-rate-accident-frequency-2009 2026-04-01T09:44:58+00:00 weekly 1 https://www.almirall.it/news/sativexr-receives-regulatory-authorisation-spain 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-signs-co-promotion-agreement-pfizer-commercialise-conbrizar-spain-new-therapeutic 2026-04-01T09:45:00+00:00 weekly 1 https://www.almirall.it/news/almirall-reaffirms-its-commitment-environment-renewal-its-iso-140012004-certificate 2026-04-01T09:45:01+00:00 weekly 1 https://www.almirall.it/news/el-tratamiento-integral-de-la-diabetes-tipo-2-y-su-cumplimiento-por-parte-del-paciente-claves 2026-04-01T09:45:01+00:00 weekly 1 https://www.almirall.it/news/presentation-neogenius-project-brings-together-around-hundred-investigators 2026-04-01T09:45:03+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-international-agreement-basilea-commercialize-toctinor-alitretinoin-severe 2026-04-01T09:45:03+00:00 weekly 1 https://www.almirall.it/news/almirall-organiza-la-i-reunion-de-centros-de-excelencia-en-cardiologia-de-espana 2026-04-01T09:45:04+00:00 weekly 1 https://www.almirall.it/news/regulators-uk-and-spain-confirm-sativexr-approvable 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almiralls-annual-general-meeting-approves-dividend-033-euros-share-figure-5-last-year 2026-04-01T09:45:05+00:00 weekly 1 https://www.almirall.it/news/almirall-first-quarter-2010-track 2026-04-01T09:45:05+00:00 weekly 1 https://www.almirall.it/news/almirall-and-forest-present-data-studies-eklirar-aclidinium-bromide-chronic-obstructive 2026-04-01T09:45:05+00:00 weekly 1 https://www.almirall.it/news/20-years-antihistamine-ebastelr-ebastine 2026-04-01T09:45:07+00:00 weekly 1 https://www.almirall.it/news/almirall-grants-eisai-marketing-rights-cinitapride-china 2026-04-01T09:45:07+00:00 weekly 1 https://www.almirall.it/news/almirall-launches-thiomucase-extreme-areas-first-anti-cellulite-stick-rebellious-areas 2026-04-01T09:45:07+00:00 weekly 1 https://www.almirall.it/news/almirall-solid-performance-2009-setting-basis-sustainable-long-term-growth 2026-04-01T09:45:09+00:00 weekly 1 https://www.almirall.it/news/neogenius-alliance-between-almirall-esteve-palau-pharma-and-proteomika-investigate-new 2026-04-01T09:45:09+00:00 weekly 1 https://www.almirall.it/news/multidisciplinary-approach-improve-treatment-and-reduce-patient-cardiovascular-risk 2026-04-01T09:45:10+00:00 weekly 1 https://www.almirall.it/news/silodosin-indicated-benign-prostatic-hyperplasia-bph-has-been-approved-european-commission 2026-04-01T09:45:10+00:00 weekly 1 https://www.almirall.it/news/almirall-strengthens-its-focus-twice-daily-dosing-eklirar-chronic-obstructive-pulmonary 2026-04-01T09:45:11+00:00 weekly 1 https://www.almirall.it/news/9th-psychiatry-symposium-organized-almirall-presents-latest-advances-area 2026-04-01T09:45:11+00:00 weekly 1 https://www.almirall.it/news/almirall-and-forest-announce-positive-results-accord-copd-i-phase-iii-study-aclidinium-bromide 2026-04-01T09:45:13+00:00 weekly 1 https://www.almirall.it/news/almirall-and-forest-laboratories-expand-respiratory-collaboration-las100977 2026-04-01T09:45:13+00:00 weekly 1 https://www.almirall.it/news/almirall-launches-parapres-plus-32r-and-parapres-plus-forter-treat-hypertension 2026-04-01T09:45:14+00:00 weekly 1 https://www.almirall.it/news/emeachmp-adopts-positive-opinion-silodosin 2026-04-01T09:45:14+00:00 weekly 1 https://www.almirall.it/news/almirall-reports-net-sales-7013-million-euros-increase-24 2026-04-01T09:45:16+00:00 weekly 1 https://www.almirall.it/news/almiralls-dhodh-inhibitor-recognized-windhover-top-10-partnering-list-immunology-category 2026-04-01T09:45:16+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-us-15-m-equity-investment-ironwood-pharmaceuticals-linaclotide 2026-04-01T09:45:17+00:00 weekly 1 https://www.almirall.it/news/update-eklirar-aclidinium-bromide-chronic-obstructive-pulmonary-disease-copd-positive-results 2026-04-01T09:45:17+00:00 weekly 1 https://www.almirall.it/news/blastoactiva-first-skin-cell-repair-cream-double-select-centella-asiatica 2026-04-01T09:45:18+00:00 weekly 1 https://www.almirall.it/news/almirall-and-spanish-society-pharmacology-present-8th-pharmacology-award-2009-seville 2026-04-01T09:45:18+00:00 weekly 1 https://www.almirall.it/news/almirall-aims-file-once-daily-aclidinium-bromide-copd-europe-early-2010 2026-04-01T09:45:18+00:00 weekly 1 https://www.almirall.it/news/almirall-reports-over-103-million-euros-net-income-first-half-year-2009 2026-04-01T09:45:20+00:00 weekly 1 https://www.almirall.it/news/almirall-offers-its-employees-6500-hours-training-health-and-safety 2026-04-01T09:45:20+00:00 weekly 1 https://www.almirall.it/news/almirall-appoints-new-managing-director-its-market-company-poland 2026-04-01T09:45:20+00:00 weekly 1 https://www.almirall.it/news/almotriptan-axertralmogranr-approved-fda-treatment-migraine-adolescents 2026-04-01T09:45:21+00:00 weekly 1 https://www.almirall.it/news/almirall-awards-dividend-payments-52-million-euros-its-shareholders 2026-04-01T09:45:21+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-filing-sativexr-regulatory-submission 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-reports-over-63-million-euros-net-income-first-quarter-2009 2026-04-01T09:45:24+00:00 weekly 1 https://www.almirall.it/news/almirall-launches-efficibr-spain-combination-product-sitagliptin-and-metformin-intended 2026-04-01T09:45:24+00:00 weekly 1 https://www.almirall.it/news/almirall-signs-pan-european-licensing-agreement-ironwood-linaclotide-novel-gastrointestinal 2026-04-01T09:45:25+00:00 weekly 1 https://www.almirall.it/news/almiralls-respiratory-pipeline-update-aclidinium-bromide-and-las100977-once-daily-laba 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-opens-its-doors-pharmaceutical-industry-mark-opening-new-london-headquarters 2026-04-01T09:45:27+00:00 weekly 1 https://www.almirall.it/news/steve-webber-new-senior-discovery-director-almirall 2026-04-01T09:45:27+00:00 weekly 1 https://www.almirall.it/news/almirall-signs-co-marketing-agreement-recordati-marketing-silodosin-spain-new-compound-benign 2026-04-01T09:45:27+00:00 weekly 1 https://www.almirall.it/news/almirall-obtains-net-income-1361-million-euros-2008-38-more-previous-year 2026-04-01T09:45:29+00:00 weekly 1 https://www.almirall.it/news/between-15-and-20-population-will-suffer-depression-some-time-during-their-lives 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/promising-results-almiralls-once-daily-long-acting-beta-agonist-laba-expected-lead-development 2026-04-01T09:45:32+00:00 weekly 1 https://www.almirall.it/news/marc-ayas-new-director-international-human-resources-and-compensation-almirall 2026-04-01T09:45:32+00:00 weekly 1 https://www.almirall.it/news/almirall-ranke-quimica-reduced-its-accident-rate-57-2007 2026-04-01T09:45:32+00:00 weekly 1 https://www.almirall.it/news/almirall-obtains-total-revenues-around-809-million-euros-18-more-same-period-previous-year 2026-04-01T09:45:34+00:00 weekly 1 https://www.almirall.it/news/almirall-signs-agreement-pfizer-commercialise-new-medicine-reduces-cardiovascular-risk 2026-04-01T09:45:34+00:00 weekly 1 https://www.almirall.it/news/almirall-signs-co-marketing-agreement-msd-commercialise-spain-new-medicine-type-2-diabetes 2026-04-01T09:45:34+00:00 weekly 1 https://www.almirall.it/news/daniel-martinez-takes-new-position-deputy-cfo-almirall 2026-04-01T09:45:36+00:00 weekly 1 https://www.almirall.it/news/almirall-upgrades-its-company-website-wwwalmirallcom 2026-04-01T09:45:36+00:00 weekly 1 https://www.almirall.it/news/almirall-moving-forward-development-aclidinium-bromide 2026-04-01T09:45:36+00:00 weekly 1 https://www.almirall.it/news/almirall-and-spanish-society-pharmacology-confer-pharmacology-award-2008 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/marketing-sales-team-almirall-germany-has-received-golden-tablet-award-best-company 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/phase-iii-clinical-studies-aclidinium-bromide-show-statistical-significance-vs-placebo 2026-04-01T09:45:39+00:00 weekly 1 https://www.almirall.it/news/clarification-regarding-news-almirall-receiving-offer-acquiring-package-almirall-shares 2026-04-01T09:45:40+00:00 weekly 1 https://www.almirall.it/news/almirall-obtains-total-revenues-around-547-million-euros-first-half-year 2026-04-01T09:45:40+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-initial-agreement-sale-its-plant-sant-just-desvern-lesvi 2026-04-01T09:45:40+00:00 weekly 1 https://www.almirall.it/news/almirall-and-proteros-biostructures-announce-successful-achievement-key-scientific-milestone 2026-04-01T09:45:42+00:00 weekly 1 https://www.almirall.it/news/laboratorios-almirall-sa-and-forest-laboratories-inc-complete-phase-iii-studies-copd 2026-04-01T09:45:42+00:00 weekly 1 https://www.almirall.it/news/doctors-and-pharmacists-pool-knowledge-tackle-digestive-diseases 2026-04-01T09:45:42+00:00 weekly 1 https://www.almirall.it/news/philippe-bouissou-new-senior-development-director-almirall 2026-04-01T09:45:43+00:00 weekly 1 https://www.almirall.it/news/almirall-and-forest-laboratories-announce-positive-results-clinical-studies-aclidinium-bromide 2026-04-01T09:45:43+00:00 weekly 1 https://www.almirall.it/news/almirall-obtains-total-revenues-269-million-euros-first-quarter-year 2026-04-01T09:45:47+00:00 weekly 1 https://www.almirall.it/news/almirall-awards-dividend-40-its-shareholders 2026-04-01T09:45:47+00:00 weekly 1 https://www.almirall.it/news/almirall-reinforces-its-european-expansion-opening-new-affiliates-poland-and-switzerland 2026-04-01T09:45:47+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-promising-results-new-compound-asthma-and-copd 2026-04-01T09:45:48+00:00 weekly 1 https://www.almirall.it/news/israel-garcia-and-ma-eugenia-vellve-new-almirall-general-managers-mexico-and-portugal 2026-04-01T09:45:48+00:00 weekly 1 https://www.almirall.it/news/almirall-reports-total-revenues-917-million-euros-2007 2026-04-01T09:45:48+00:00 weekly 1 https://www.almirall.it/news/carlos-gallardo-general-manager-almirall-united-kingdom-and-ireland 2026-04-01T09:45:49+00:00 weekly 1 https://www.almirall.it/news/almirall-reinforces-its-presence-europe-opening-new-affiliate-united-kingdom 2026-04-01T09:45:49+00:00 weekly 1 https://www.almirall.it/news/almirall-closes-acquisition-portfolio-8-products-shire-plc 2026-04-01T09:45:52+00:00 weekly 1 https://www.almirall.it/news/almirall-contributes-almost-2-million-euros-renew-collaboration-agreement-barcelona-science 2026-04-01T09:45:52+00:00 weekly 1 https://www.almirall.it/news/almirall-increases-its-net-sales-38 2026-04-01T09:45:53+00:00 weekly 1 https://www.almirall.it/news/christophe-vandeputte-and-dominique-humblet-new-almirall-general-managers-france-and-belgium 2026-04-01T09:45:55+00:00 weekly 1 https://www.almirall.it/news/anselm-divi-new-almirall-corporate-director-human-resources 2026-04-01T09:45:57+00:00 weekly 1 https://www.almirall.it/news/almirall-acquires-portfolio-eight-products-shire-plc-us213-million-eu151-million 2026-04-01T09:45:59+00:00 weekly 1 https://www.almirall.it/news/klaus-melchers-new-senior-discovery-director-almirall 2026-04-01T09:45:59+00:00 weekly 1 https://www.almirall.it/news/almirall-and-spanish-pharmacology-society-confer-pharmacology-award-2007 2026-04-01T09:45:59+00:00 weekly 1 https://www.almirall.it/news/aclidinium-bromide-demonstrates-rapid-and-long-acting-bronchodilatory-effect-copd 2026-04-01T09:46:00+00:00 weekly 1 https://www.almirall.it/news/almirall-closes-process-acquisition-hermal-after-clearance-german-regulatory-authorities 2026-04-01T09:46:00+00:00 weekly 1 https://www.almirall.it/news/almirall-closes-its-acquisition-hermal-after-clearance-german-regulatory-authorities 2026-04-01T09:46:02+00:00 weekly 1 https://www.almirall.it/news/almirall-half-year-results-2007-almirall-reports-net-sales-4129-million-euros 2026-04-01T09:46:02+00:00 weekly 1 https://www.almirall.it/news/almirall-reports-net-sales-4129-million-euros 2026-04-01T09:46:02+00:00 weekly 1 https://www.almirall.it/news/almirall-again-receives-iso-140012004-environmental-management-certificate 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-acquires-hermal-european-prescription-dermatology-business-reckitt-benckiser-ps-255 2026-04-01T09:46:05+00:00 weekly 1 https://www.almirall.it/news/almirall-priced-14-euros-share-its-first-day-listed-company 2026-04-01T09:46:05+00:00 weekly 1 https://www.almirall.it/news/almirall-shares-close-first-day-trading-rising-714-over-offer-price 2026-04-01T09:46:06+00:00 weekly 1 https://www.almirall.it/news/jordi-molina-alsina-investor-relations-manager-almirall 2026-04-01T09:46:06+00:00 weekly 1 https://www.almirall.it/news/CNMV-spanish-stock-exchange-commission-registers-prospectus-public-offering-sale-and 2026-04-01T09:46:07+00:00 weekly 1 https://www.almirall.it/news/almirall-will-reserve-shares-its-stock-market-listing-company-employees 2026-04-01T09:46:07+00:00 weekly 1 https://www.almirall.it/news/sativex 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-receives-fundamed-el-global-award-best-pharmaceutical-company-year 2026-04-01T09:46:08+00:00 weekly 1 https://www.almirall.it/news/almirall-certifies-its-occupational-risk-prevention-management-system-surpassing-current 2026-04-01T09:46:10+00:00 weekly 1 https://www.almirall.it/news/almirall-selects-morgan-stanley-and-santander-next-phase-stock-market-listing 2026-04-01T09:46:10+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-its-intention-list-its-shares-spanish-stock-market 2026-04-01T09:46:10+00:00 weekly 1 https://www.almirall.it/news/almirall-and-council-catalonian-medical-associations-fundacio-galatea-sign-agreement-undertake 2026-04-01T09:46:11+00:00 weekly 1 https://www.almirall.it/news/almirall-spa-be-awarded-spanish-company-year-italy 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/stress-and-anxiety-are-among-main-causes-acidity-spain 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-confers-2006-pharmacology-award-during-spanish-pharmacology-society-congress 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-extends-its-collaboration-sareum 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/strategic-partnership-almirall-meda 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/his-majesty-king-spain-inaugurates-almiralls-new-research-and-development-centre-sant-feliu-de 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almiralls-new-research-and-development-centre-reference-point-biomedical-research 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-expands-12-international-pharmaceutical-market 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/el-dr-carsten-niederlander-nuevo-director-de-desarrollo-farmaceutico 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-and-forest-announce-development-and-marketing-collaboration-agreement-new-therapy 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-publish-clinical-trials 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-and-gw-announce-european-development-and-marketing-agreement-sativexr 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-grants-commercialisation-almogran-switzerland-pharmaceutical-company-merz 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-italy-signs-agreement-altana-pharma-ag-commercialisation-pantopan-pantoprazole 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-only-pharmaceutical-company-be-awarded-best-european-business-prize-innovation 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-confers-2005-pharmacology-award 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-collaboration-sareum-protein-structure-determination 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-enters-long-term-compound-library-agreement-evotec 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/according-survey-el-club-de-la-farmacia-website-portal-which-over-30000-pharmacists-subscribe 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-reaches-sales-figures-900-million-euros-2004 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-awarded-prince-felipe-prize-business-competitiveness-large-enterprises-ministry 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-parkinsons-disease-research-programme-licensing-agreement-neurocrine 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-confers-2004-pharmacology-award 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-has-taken-strategic-decision-registering-almotriptan-japan 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-increases-sales-64-2003 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almotriptan-receives-approval-be-sold-canada 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-awarded-iso-1400196-environmental-management-certification 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-confers-2003-pharmacology-award 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/canada-another-key-approval-almotriptan 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-presents-its-new-corporate-website 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-has-licensed-its-triptan-ortho-mcneil-pharmaceutical-inc-us-and-canada 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-prodesfarma-consolidates-its-international-expansion-opening-subsidiary-italy 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-prodesfarma-confers-2002-pharmacology-award 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-prodesfarma-invests-30-million-euros-new-research-and-development-centre 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/comparative-study-classifies-almogran-one-best-choices-treatment-migraines 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-prodesfarma-opens-new-laboratory-barcelona-science-park 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-prodesfarma-establishes-its-presence-france-acquisition-pharmafarm-laboratories 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-prodesfarma-licenses-antipsychotic-agent-blonanserin-dainippon 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almotriptan-almogran-licensed-fda-marketing-united-states 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-prodesfarma-acquires-prasfarma 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-recognized-top-employer-spain-and-germany 2026-03-30T13:39:13+00:00 weekly 1 https://www.almirall.it/news/dr-olof-andersson-new-executive-director-rd-area-almirall 2026-04-01T11:26:17+00:00 weekly 1 https://www.almirall.it/news/dr-john-efthimiou-new-rd-global-medical-director-almirall 2026-04-01T11:29:57+00:00 weekly 1 https://www.almirall.it/news/almirall-presents-rd-pipeline-advances-supported-sustained-growth-and-leadership-medical 2026-04-01T11:30:07+00:00 weekly 1 https://www.almirall.it/news/gonzalo-de-miquel-new-global-medical-director-almirall-rd-area 2026-04-01T11:30:51+00:00 weekly 1 https://www.almirall.it/news/first-half-2010-line-guidance-strong-rd-catalysts-expected-second-half 2026-04-01T11:31:01+00:00 weekly 1 https://www.almirall.it/news/q3-line-guidance-rd-momentum-continues 2026-04-01T11:31:09+00:00 weekly 1 https://www.almirall.it/news/bertil-lindmark-new-executive-director-rd-almirall 2026-04-01T11:31:18+00:00 weekly 1 https://www.almirall.it/news/almirall-opens-doors-its-rd-centre-biotech-zeclinics 2026-04-01T11:31:41+00:00 weekly 1 https://www.almirall.it/news/almirall-maintains-its-shareholder-return-thanks-its-rd-and-internationalisation-results 2026-04-01T11:31:45+00:00 weekly 1 https://www.almirall.it/news/almirall-and-eloxx-pharmaceuticals-enter-exclusive-agreement-license-zkn-013-rare 2026-04-01T13:10:01+00:00 weekly 1 https://www.almirall.it/news/encouraging-results-support-further-development-almiralls 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-receipt-15-million-dollars-eu105-million-forest-laboratories-connection 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-commemorates-5th-anniversary-almogran-its-own-rd-medicine-treatment-migraine 2026-04-01T11:39:47+00:00 weekly 1 https://www.almirall.it/news/almirall-reveals-promising-phase-ii-data-its-once-daily-long-acting-low-systemic-exposure 2026-04-01T12:10:01+00:00 weekly 1 https://www.almirall.it/news/almirall-commemorates-5th-anniversary-almogran-its-own-rd-medicine-treatment-migraine-0 2026-04-01T16:01:10+00:00 weekly 1 https://www.almirall.it/news/dr-olof-andersson-new-executive-director-rd-area-almirall-0 2026-04-01T16:01:24+00:00 weekly 1 https://www.almirall.it/news/dr-john-efthimiou-new-rd-global-medical-director-almirall-0 2026-04-01T16:01:32+00:00 weekly 1 https://www.almirall.it/news/gonzalo-de-miquel-new-global-medical-director-almirall-rd-area-0 2026-04-01T16:01:40+00:00 weekly 1 https://www.almirall.it/news/first-half-2010-line-guidance-strong-rd-catalysts-expected-second-half-0 2026-04-01T16:01:44+00:00 weekly 1 https://www.almirall.it/news/q3-line-guidance-rd-momentum-continues-0 2026-04-01T16:01:49+00:00 weekly 1 https://www.almirall.it/news/bertil-lindmark-new-executive-director-rd-almirall-0 2026-04-01T16:01:54+00:00 weekly 1 https://www.almirall.it/news/almirall-maintains-its-shareholder-return-thanks-its-rd-and-internationalisation-results-0 2026-04-01T16:01:59+00:00 weekly 1 https://www.almirall.it/news/almirall-opens-doors-its-rd-centre-biotech-zeclinics-0 2026-04-01T16:02:03+00:00 weekly 1 https://www.almirall.it/news/almirall-presents-rd-pipeline-advances-supported-sustained-growth-and-leadership-medical-0 2026-04-01T16:02:10+00:00 weekly 1 https://www.almirall.it/news/almirall-announces-approval-seysarar-china-treatment-moderate-severe-acne 2026-04-07T08:46:40+00:00 weekly 1 https://www.almirall.it/news-media/newsroom/diversi-scelta-un-nuovo-modo-di-pensare-plasmare-il-futuro-della-dermatologia 2026-06-03T09:57:56+00:00 weekly 1 https://www.almirall.it/news-media/newsroom/skin-academy-avanzando-nello-scambio-scientifico-e-nella-cura-olistica 2026-06-03T14:33:57+00:00 weekly 1 https://www.almirall.it/news-media/newsroom/promuovere-linnovazione-nella-dermatologia-medica-attraverso-partnership-cina 2026-06-04T09:18:45+00:00 weekly 1 https://www.almirall.it/news-media/newsroom/donne-il-progresso-della-scienza 2026-06-04T09:22:39+00:00 weekly 1 https://www.almirall.it/news-media/newsroom/almirall-raggiunge-gli-obiettivi-previsti-il-2025-registrando-una-crescita-del 2026-06-04T09:24:51+00:00 weekly 1 https://www.almirall.it/dermatologia/acne 2026-08-17T12:21:44+00:00 weekly 1 https://www.almirall.it/dermatologia/alopecia-areata 2026-07-07T09:39:22+00:00 weekly 1 https://www.almirall.it/dermatologia/carcinoma-cheratinociti 2026-08-17T10:55:23+00:00 weekly 1 https://www.almirall.it/dermatologia/cheratosi-attinica 2026-08-17T12:37:36+00:00 weekly 1 https://www.almirall.it/dermatologia/dermatite-atopica 2026-07-07T09:33:26+00:00 weekly 1 https://www.almirall.it/dermatologia/acne/diagnosi 2026-06-24T10:53:41+00:00 weekly 1 https://www.almirall.it/dermatologia/malattie-rare-pelle/epidermolisi-bollosa-congenita/diagnosi 2026-05-13T13:52:57+00:00 weekly 1 https://www.almirall.it/dermatologia/psoriasi/diagnosi 2026-08-17T12:04:31+00:00 weekly 1 https://www.almirall.it/dermatologia/malattie-rare-pelle/pustolosi-palmoplantare/diagnosi 2026-05-13T11:30:21+00:00 weekly 1 https://www.almirall.it/dermatologia/vitiligine/diagnosi 2026-07-08T09:20:03+00:00 weekly 1 https://www.almirall.it/dermatologia/onicomicosi/diagnosi 2026-08-17T11:34:38+00:00 weekly 1 https://www.almirall.it/dermatologia/alopecia-areata/diagnosi 2026-08-17T12:34:18+00:00 weekly 1 https://www.almirall.it/dermatologia/carcinoma-cheratinociti/diagnosi 2026-07-09T06:22:02+00:00 weekly 1 https://www.almirall.it/dermatologia/cheratosi-attinica/diagnosi 2026-07-07T06:59:43+00:00 weekly 1 https://www.almirall.it/dermatologia/dermatite-atopica/diagnosi 2026-06-03T16:57:38+00:00 weekly 1 https://www.almirall.it/dermatologia/idrosadenite-suppurativa/diagnosi 2026-06-24T07:28:02+00:00 weekly 1 https://www.almirall.it/dermatologia/malattie-rare-pelle/epidermolisi-bollosa-congenita 2026-07-07T09:45:48+00:00 weekly 1 https://www.almirall.it/dermatologia/carcinoma-cheratinociti/fattori-scatenanti 2026-06-24T09:23:19+00:00 weekly 1 https://www.almirall.it/dermatologia/acne/fattori-scatenanti 2026-06-03T16:38:50+00:00 weekly 1 https://www.almirall.it/dermatologia/alopecia-areata/fattori-scatenanti 2026-05-13T17:44:15+00:00 weekly 1 https://www.almirall.it/dermatologia/malattie-rare-pelle/epidermolisi-bollosa-congenita/fattori-scatenanti 2026-06-24T07:18:44+00:00 weekly 1 https://www.almirall.it/dermatologia/idrosadenite-suppurativa/fattori-scatenanti 2026-06-24T07:30:43+00:00 weekly 1 https://www.almirall.it/dermatologia/cheratosi-attinica/fattori-scatenanti 2026-08-17T12:23:36+00:00 weekly 1 https://www.almirall.it/dermatologia/dermatite-atopica/fattori-scatenanti 2026-06-03T17:10:15+00:00 weekly 1 https://www.almirall.it/dermatologia/psoriasi/fattori-scatenanti 2026-06-24T13:47:25+00:00 weekly 1 https://www.almirall.it/dermatologia/malattie-rare-pelle/pustolosi-palmoplantare/fattori-scatenanti 2026-05-13T11:54:29+00:00 weekly 1 https://www.almirall.it/dermatologia/vitiligine/fattori-scatenanti 2026-05-13T16:05:47+00:00 weekly 1 https://www.almirall.it/dermatologia/onicomicosi/fattori-scatenanti 2026-08-17T11:01:00+00:00 weekly 1 https://www.almirall.it/dermatologia/idrosadenite-suppurativa 2026-07-07T09:40:54+00:00 weekly 1 https://www.almirall.it/dermatologia/malattie-rare-pelle 2026-05-19T09:50:51+00:00 weekly 1 https://www.almirall.it/dermatologia/onicomicosi 2026-07-07T09:39:11+00:00 weekly 1 https://www.almirall.it/dermatologia/psoriasi 2026-08-17T12:44:53+00:00 weekly 1 https://www.almirall.it/dermatologia/malattie-rare-pelle/pustolosi-palmoplantare 2026-07-07T09:46:16+00:00 weekly 1 https://www.almirall.it/dermatologia/carcinoma-cheratinociti/segni-sintomi 2026-06-25T07:52:07+00:00 weekly 1 https://www.almirall.it/dermatologia/acne/segni-sintomi 2026-08-17T11:12:51+00:00 weekly 1 https://www.almirall.it/dermatologia/alopecia-areata/segni-sintomi 2026-06-24T09:33:21+00:00 weekly 1 https://www.almirall.it/dermatologia/malattie-rare-pelle/epidermolisi-bollosa-congenita/segni-sintomi 2026-06-23T14:22:08+00:00 weekly 1 https://www.almirall.it/dermatologia/idrosadenite-suppurativa/segni-sintomi 2026-06-25T06:26:19+00:00 weekly 1 https://www.almirall.it/dermatologia/cheratosi-attinica/segni-sintomi 2026-08-17T12:26:19+00:00 weekly 1 https://www.almirall.it/dermatologia/dermatite-atopica/segni-sintomi 2026-07-16T11:42:51+00:00 weekly 1 https://www.almirall.it/dermatologia/psoriasi/segni-sintomi 2026-08-17T12:18:28+00:00 weekly 1 https://www.almirall.it/dermatologia/malattie-rare-pelle/pustolosi-palmoplantare/segni-sintomi 2026-05-13T11:41:22+00:00 weekly 1 https://www.almirall.it/dermatologia/vitiligine/segni-sintomi 2026-06-03T16:08:48+00:00 weekly 1 https://www.almirall.it/dermatologia/onicomicosi/segni-sintomi 2026-08-17T11:23:09+00:00 weekly 1 https://www.almirall.it/dermatologia/alopecia-areata/tipi 2026-05-13T17:24:17+00:00 weekly 1 https://www.almirall.it/dermatologia/carcinoma-cheratinociti/tipi 2026-08-17T11:06:27+00:00 weekly 1 https://www.almirall.it/dermatologia/cheratosi-attinica/tipi 2026-08-17T12:32:19+00:00 weekly 1 https://www.almirall.it/dermatologia/dermatite-atopica/tipi 2026-06-03T16:51:36+00:00 weekly 1 https://www.almirall.it/dermatologia/malattie-rare-pelle/epidermolisi-bollosa-congenita/tipi 2026-05-12T13:21:34+00:00 weekly 1 https://www.almirall.it/dermatologia/idrosadenite-suppurativa/tipi 2026-06-03T15:17:38+00:00 weekly 1 https://www.almirall.it/dermatologia/onicomicosi/tipi 2026-05-13T17:46:08+00:00 weekly 1 https://www.almirall.it/dermatologia/psoriasi/tipi 2026-07-09T06:45:03+00:00 weekly 1 https://www.almirall.it/dermatologia/malattie-rare-pelle/pustolosi-palmoplantare/tipi 2026-06-23T14:05:11+00:00 weekly 1 https://www.almirall.it/dermatologia/vitiligine/tipi 2026-06-24T08:15:22+00:00 weekly 1 https://www.almirall.it/dermatologia/acne/tipi 2026-06-24T10:51:58+00:00 weekly 1 https://www.almirall.it/dermatologia/carcinoma-cheratinociti/trattamento 2026-07-08T09:12:09+00:00 weekly 1 https://www.almirall.it/dermatologia/malattie-rare-pelle/pustolosi-palmoplantare/trattamento 2026-06-23T14:07:26+00:00 weekly 1 https://www.almirall.it/dermatologia/acne/trattamento 2026-08-17T11:09:57+00:00 weekly 1 https://www.almirall.it/dermatologia/alopecia-areata/trattamento 2026-06-24T10:31:22+00:00 weekly 1 https://www.almirall.it/dermatologia/malattie-rare-pelle/epidermolisi-bollosa-congenita/trattamento 2026-05-12T13:24:40+00:00 weekly 1 https://www.almirall.it/dermatologia/idrosadenite-suppurativa/trattamento 2026-06-24T08:13:02+00:00 weekly 1 https://www.almirall.it/dermatologia/cheratosi-attinica/trattamento 2026-07-08T07:38:41+00:00 weekly 1 https://www.almirall.it/dermatologia/dermatite-atopica/trattamento 2026-07-09T06:33:35+00:00 weekly 1 https://www.almirall.it/dermatologia/psoriasi/trattamento 2026-08-17T11:37:50+00:00 weekly 1 https://www.almirall.it/dermatologia/vitiligine/trattamento 2026-05-13T16:19:38+00:00 weekly 1 https://www.almirall.it/dermatologia/onicomicosi/trattamento 2026-07-08T08:07:23+00:00 weekly 1 https://www.almirall.it/dermatologia/vitiligine 2026-07-07T09:40:41+00:00 weekly 1